Literature DB >> 23744097

Cutaneous manifestations of primary immunodeficiency.

Johannes H Sillevis Smitt1, Taco W Kuijpers.   

Abstract

PURPOSE OF REVIEW: To show that skin symptoms help in the recognition of primary immunodeficiencies (PIDs). To analyze whether recent molecular data help in understanding genotype/phenotype relations. RECENT
FINDINGS: Erythroderma in Omenn syndrome may be caused by either mutations in genes associated with severe combined immunodeficiency (SCID) in which the generation of some T cells is possible, which results in potentially autoreactive lymphoid clones, or by selective proliferation of revertant CD8 T cells in the skin due to clonal expansion in response to infections or autoantigens.The newborn eczematous eruption, which occurs mainly in the signal-transducer-and-activator-of-transcription-3 (STAT3) variant, helps to differentiate STAT3 from Dedicator of Cytokinesis 8-related Hyper-IgE-syndrome (HIES).Impaired T helper 17 cell (TH17) immunity [HIES and defects of autoimmune regulator element (AIRE), STAT-1, and interleukin17 receptor(IL17(R))] may give rise to localized chronic mucocutaneous candidiasis, whereas a defective innate immune system predisposes to systemic candidiasis [congenital neutropenia, neutrophil dysfunction, and caspase recruitment domain 9 (CARD9) deficiency].Noninfectious granulomas may be the presenting symptom in innate immunity defects [such as chronic granulomatous disease (CGD) or in predominantly humoral immunodeficiencies such as common variable immunodeficiency], as well as ataxia teleangiectasia or rare recombination-activating gene-deficient cases.
SUMMARY: The skin is important in the diagnosis of PIDs. In particular eczematous lesions, erythroderma, noninfectious granuloma, and microbial manifestations may help to direct further diagnostic laboratory analysis.

Entities:  

Mesh:

Year:  2013        PMID: 23744097     DOI: 10.1097/MOP.0b013e3283623b9f

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  16 in total

1.  Food allergy in patients with primary immunodeficiency diseases: prevalence within the US Immunodeficiency Network (USIDNET).

Authors:  Karen S Tuano; Jordan S Orange; Kathleen Sullivan; Charlotte Cunningham-Rundles; Francisco A Bonilla; Carla M Davis
Journal:  J Allergy Clin Immunol       Date:  2014-11-25       Impact factor: 10.793

2.  Distinct Cutaneous Manifestations and Cold-Induced Leukocyte Activation Associated With PLCG2 Mutations.

Authors:  Oyinade M Aderibigbe; Debra Long Priel; Chyi-Chia Richard Lee; Michael J Ombrello; Vimal H Prajapati; Marilyn G Liang; Jonathan J Lyons; Douglas B Kuhns; Edward W Cowen; Joshua D Milner
Journal:  JAMA Dermatol       Date:  2015-06       Impact factor: 10.282

Review 3.  Rheumatologic manifestations of primary immunodeficiency diseases.

Authors:  V R Dimitriades; R Sorensen
Journal:  Clin Rheumatol       Date:  2016-03-14       Impact factor: 2.980

4.  Rubella persistence in epidermal keratinocytes and granuloma M2 macrophages in patients with primary immunodeficiencies.

Authors:  Ludmila Perelygina; Stanley Plotkin; Pierre Russo; Timo Hautala; Francisco Bonilla; Hans D Ochs; Avni Joshi; John Routes; Kiran Patel; Claudia Wehr; Joseph Icenogle; Kathleen E Sullivan
Journal:  J Allergy Clin Immunol       Date:  2016-09-06       Impact factor: 10.793

5.  Prevalence of Granulomas in Patients With Primary Immunodeficiency Disorders, United States: Data From National Health Care Claims and the US Immunodeficiency Network Registry.

Authors:  Jessica Leung; Kathleen E Sullivan; Ludmila Perelygina; Joseph P Icenogle; Ramsay L Fuleihan; Tatiana M Lanzieri
Journal:  J Clin Immunol       Date:  2018-07-24       Impact factor: 8.317

Review 6.  Primary immunodeficiencies underlying fungal infections.

Authors:  Fanny Lanternier; Sophie Cypowyj; Capucine Picard; Jacinta Bustamante; Olivier Lortholary; Jean-Laurent Casanova; Anne Puel
Journal:  Curr Opin Pediatr       Date:  2013-12       Impact factor: 2.856

Review 7.  Idiopathic, Refractory Sweet's Syndrome Associated with Common Variable Immunodeficiency: a Case Report and Literature Review.

Authors:  Quindelyn S Cook; Carlton J Zdanski; Craig N Burkhart; Paul B Googe; Patrick Thompson; Eveline Y Wu
Journal:  Curr Allergy Asthma Rep       Date:  2019-05-14       Impact factor: 4.919

Review 8.  Diagnosis of Atopic Dermatitis: Mimics, Overlaps, and Complications.

Authors:  Elaine C Siegfried; Adelaide A Hebert
Journal:  J Clin Med       Date:  2015-05-06       Impact factor: 4.241

Review 9.  IL-23/IL-17A Dysfunction Phenotypes Inform Possible Clinical Effects from Anti-IL-17A Therapies.

Authors:  Andrew Blauvelt; Mark G Lebwohl; Robert Bissonnette
Journal:  J Invest Dermatol       Date:  2015-03-24       Impact factor: 8.551

Review 10.  The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations.

Authors:  Mario Sánchez-Borges; Ignacio J Ansotegui; Ilaria Baiardini; Jonathan Bernstein; Giorgio Walter Canonica; Motohiro Ebisawa; R Maximiliano Gomez; Sandra González-Diaz; Bryan Martin; Mário Morais de Almeida; Jose Antonio Ortega Martell
Journal:  World Allergy Organ J       Date:  2021-06-03       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.